| |
Finding A Cure!
Websites are listed in the order that they were
added.
Newest additions are at the bottom of this page.
Defects give the immune system the green light to attack the
pancreas
(http://www.joslinresearch.org/PINET/InvestigatorDetail.asp?InvestigatorID=11)
The Diabetes Projects.
The Walter and Eliza Hall
Institute of Medical Research (http://www.wehi.edu.au/)
Professor Paul Lacy, M.D., Ph.D. (http://wupa.wustl.edu/record/archive/1997/03-27-97/1511.html)
Dr. Lacy is a well-known researcher in the field of diabetes.
Closing In on Mouse Diabetes and Obesity (http://www.ornl.gov/ORNLReview/rev27-12/text/mnmmain.html)
Research information, including some about diabetes, from the Oak
Ridge National Laboratory.
Clinical
Trials: Diabetes Mellitus Types I and II (http://www.centerwatch.com/studies/CAT55.HTM)
At Centerwatch: a listing of where and what is underway.
Dr.
Christian Renner ("http://www.franken.de/users/daneel/C.Renner/")
Dr. Renner is a scientist/physician who is interested in diabetes
Dr. Allan
Frey (http://www.med.nyu.edu/people/A.Frey.html) Dr. Frey
has investigated the immunological basis of Type 1 diabetes
Insulin Receptor Signaling Pathways (http://www.med.nyu.edu/Research/E.Skolnik-res.html)
Includes a complicated diagram of what's going on at the insulin
receptor (and some nice research lingo to wow your doctor!) By Dr.
Edward Skolnik of the Departments of Medicine and Pharmacology at
the New York University Medical Center.
Intensive
Insulin Therapy (http://www.ibib.waw.pl/~esao96/psdl.html)
From the Institute of Biocybernetics and Biomedical Engineering at
the Polish Academy of Sciences Drug Delivery Systems Laboratory.
Upcoming
Diabetes Medications (http://www.diabetesmonitor.com/newdrugs.htm)
What medications might soon be available to help people with
diabetes. From the Diabetes Monitor.
The Diabetes Research
International (http://www.drinet.org/) "The Diabetes
Research Institute (DRI) is an international center dedicated
exclusively to the cure and treatment of diabetes."
Research into Prevention(http://www.childrenwithdiabetes.com/d_0n_500.htm)
"Science has learned much about Type 1 diabetes in recent years.
This knowledge is being applied in several ways to identify the
underlying causes of and ways to prevent diabetes. Here are several
examples." At Children with DIABETES.
The Islet Foundation
(http://www.islet.org) "The Islet Foundation... Help us complete the
puzzle"
Testing Drugs in People (http://www.fda.gov//fdac/special/newdrug/testing.html)
"Most of us understand that drugs intended to treat people have to
be tested in people. These tests, called clinical trials, determine
if a drug is safe and effective, at what doses it works best, and
what side effects it causes--information that guides health
professionals and, for nonprescription drugs, consumers in the
proper use of medicines." At the U.S. Food and Drug Administration
website; written by Ken Flieger.
The Whittier
Institute for Diabetes (http://www.scrippshealth.org/whittier/)
"A subsidiary of Scripps dedicated to diabetes research, education
and patient care through a collaborative program with the University
of California, San Diego. The mission of this web site, Whittier.org,
is to acquaint you with the extensive research efforts being made at
The Whittier Institute for Diabetes."
Sansum Medical Reseach
Institute(http://www.sansum.org) "The mission of the
Institute is to conduct basic and applied research on the cause,
prevention and treatment of disease. Diabetes remains the principal
and continuing area of study."
Alberta Foundation for Diabetes
Research (Canada) (http://afdr.ab.ca/) "The purpose of the
Alberta Foundation for Diabetes Research is to raise funds to
support clinical trials, as well as other promising diabetes
research projects being carried out in Alberta."
The Immunology of Diabetes
Society(http://www.idsoc.org) "The Immunology of Diabetes
Society is an international collaborative initiative set up to
advance research related to the etiology, pathogenesis, prevention
and cure of type 1 diabetes."
WHO
DIAMOND Project (http://www.pitt.edu/~iml1/diabetes/DIAMOND.html)
"Insulin-dependent diabetes mellitus (IDDM) is one of the most
important chronic diseases of children worldwide. A 60-fold
international gradient in IDDM incidence has been reported and
epidemic periods have been identified. The World Health Organization
(WHO) Multinational Project for Childhood Diabetes (WHO DIAMOND
Project) has been developed to investigate and characterize global
incidence, mortality and health care. Over 10 years (1990-1999),
this study will collect population-based data concerning IDDM in
more than 100 centers in 60 countries worldwide."
Diabetes and
Endocrinology Research Center(http://www.medicine.uiowa.edu/uiderc/)
"The Iowa Diabetes and Endocrinology Research Center (DERC) is one
of 13 Diabetes Centers in the country. Now in its 23rd year of
operation, the Iowa DERC fosters a multidisciplinary approach to the
study of diabetes, diabetic complications and hormone action at the
cellular and molecular level."
Diabetes Research
Laboratories ("http://www.drl.ox.ac.uk/") "The Diabetes
Research Laboratories (DRL), situated in the Radcliffe Infirmary,
are an integral part of the Nuffield Department of Clinical Medicine
at the University of Oxford. The DRL, founded in 1976, is the
largest clinical diabetes research unit in the UK and consists of a
consortium of four research groups."
Alberta Foundation Reports on Successful Islet Transplants
(http://www.childrenwithdiabetes.com/d_0j_115.htm)
Research News and Information (http://www.childrenwithdiabetes.com/d_0j_100.htm)
At Children with DIABETES.
Diabetes Research and Training Center's Demonstration and Education
Divisions "The Diabetes Research and Training Center (DRTC)
program was established in 1977 by the Diabetes Research and
Education Act (Public Law 91-354) in response to a recommendation by
the National Commission on Diabetes. Currently, six DRTCs are
supported by the National Institute of Diabetes and Digestive and
Kidney Diseases (NIDDK). The National Institute of Diabetes and
Digestive and Kidney Diseases (NIDDK) supports six DRTCs across the
United States:"
Albert
Einstein DRTC Bronx, NY 10461 Tel: (718) 430-3345 Fax: (718)
430-8634
Indiana University DRTC Indiana University School of
Medicine Indianapolis, IN 46202 Tel: (317) 278-0905 Fax: (317)
278-0911
Michigan DRTC University of Michigan Medical School Ann
Arbor, MI 48109-0201 Tel: (734) 763-1426 or (734) 763-5739
(Secretary) Fax: (734) 936-1641
Michigan Diabetes
Research and Training Center (http://www.med.umich.edu/mdrtc/)
University of Chicago DRTC University of Chicago Department
of Medicine Chicago, IL 60637 Tel: (773) 753-1310 Fax: (773)
753-1316
Vanderbilt University DRTC Diabetes Research and Training
Center of Vanderbilt Medical School Nashville, TN 37212 Tel: (615)
936-1149 Fax: (615) 936-1152
Vanderbilt Diabetes Center (http://www.mc.vanderbilt.edu/root/genss.html?subsiteid=25)
Washington University DRTC Washington University School of
Medicine St. Louis, MO 63108 Tel: (314) 286-1900 Fax: (314)
286-1919
The University
of Washington Diabetes Endocrinology Research Center (DERC)
(http://depts.washington.edu/diabetes/)
Research
(http://www.diabetesmonitor.com/dr-00006.htm) At the Diabetes
Registry; from the Diabetes Monitor.
Universities,
Hospitals, M.D.'s, and Research Web Sites (http://www.diabetesmonitor.com/univ.htm)
By David Mendosa
Diabetes TrialNet(http://www.diabetestrialnet.org)
"The goal of the prevention trials is to stop or delay the immune
destruction of the insulin-producing beta cells of the pancreas in
people at risk for type 1 diabetes, an autoimmune disease."
The Loop Club(http://www.loopclub.org/)
"The ultimate goal is 'TO CLOSE THE LOOP', namely that such a sensor
would be tied to an implanted insulin pump that would be able to
deliver the correct amount of insulin at the exact time it is
needed, without involving the patient in the process, thus creating
an artificial pancreas."
New
Navigator(http://www.navigatortrial.com)
"...the world's largest ever diabetes prevention trial, with 9,150
people taking part in 39 countries around the world. The aim of the
Navigator study is to investigate means to prevent type 2 diabetes
and cardiovascular diseases such as heart disease and stroke in
people who are at greater risk of these diseases. All the
participants in Navigator have a condition called impaired glucose
tolerance (IGT)...
New
DREAM(http://www.dream-ctn.org/)
"...a new international clinical trial to study drug prevention of
type 2 diabetes mellitus. DREAM will determine if ramipril and
rosiglitazone, used alone or together can prevent type 2 diabetes
mellitus in patients with impaired glucose (blood sugar) tolerance."
|
|
|